- €5.27bn
- €8.91bn
- €4.57bn
- 67
- 49
- 85
- 80
Annual balance sheet for Elis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 138 | 160 | 286 | 665 | 622 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 558 | 656 | 810 | 900 | 914 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 852 | 974 | 1,309 | 1,770 | 1,764 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,322 | 2,350 | 2,507 | 2,724 | 2,925 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7,862 | 8,040 | 8,634 | 9,302 | 9,387 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,103 | 1,065 | 1,457 | 2,142 | 2,148 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,056 | 5,026 | 5,423 | 5,827 | 5,789 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,806 | 3,013 | 3,212 | 3,476 | 3,598 |
Total Liabilities & Shareholders' Equity | 7,862 | 8,040 | 8,634 | 9,302 | 9,387 |
Total Common Shares Outstanding |